Dr. Darren W. Schmidt, MD

Dr. Schmidt practices at Dialysis Clinic - Albuquerque (Indian School Rd NE) in Albuquerque, New Mexico.

Dr. Schmidt's NPI, 1134159692, was assigned on July 3, 2006. Dr. Schmidt holds New Mexico license 2002-0186.

Dr. Schmidt's primary practice is Dialysis Clinic - Albuquerque (Indian School Rd NE), at 1500 Indian School Road Ne, Albuquerque, NM 87102 in Bernalillo County. The practice phone is (505) 724-1500.

Dr. Schmidt's primary practice is Dialysis Clinic - Albuquerque (Indian School Rd NE) in Albuquerque, New Mexico. Dr. Schmidt is also affiliated with University of New Mexico Hospital. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Schmidt to 1 more hospital and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmidt practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Schmidt's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Schmidt's licenses on file in 2 states: New Mexico and Mississippi.

CMS data shows 382 Medicare services from Dr. Schmidt across 7 procedure codes in 2024, for 167 Medicare patients. Medicare paid $51,547 for them.

CMS counts 167 Medicare patients who saw Dr. Schmidt in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 44% are also on Medicaid. Their average risk score is 4.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schmidt's median patient age at 72, with 46% women.

In 2024, Dr. Schmidt wrote 850 Medicare Part D claims for 125 patients. 88% of them were for generic drugs. CMS names the drug for 672 of them, across 23 drugs with 11 or more claims each, at $89,068 in total drug cost. In 2023, CMS named 622 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Schmidt for performance year 2024, reported as part of a group. Dr. Schmidt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Schmidt, published from 2014 to 2025. 2023 was the busiest year, with 2. Dr. Schmidt has published most often in Rev Sci Instrum. Dr. Schmidt's most frequent co-authors are Christos P. Argyropoulos, MD, PhD, Eric Dk Brooks, MD, MHS and David Walter Casavant, MD.

CMS Open Payments shows 25 general payments to Dr. Schmidt from 8 drug and device companies from 2017 to 2023. Travel and lodging make up the largest share, 62% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,225.